Advertisement
CStone Pharmaceuticals

Stay Updated with the Latest CStone Pharmaceuticals 2616.HK News in Real Time

Find 2616.HK news now at Meyka AI. Stay informed with the latest CStone Pharmaceuticals stocks updates, including price news, market analysis, and expert insights.

2616.HKHKSE
HealthcareBiotechnology
HK$4.41
HK$0.19(4.13%)
Hong Kong Market opens in 39h 18m
Advertisement
Diksha Polymers Share Price Hits 5% Upper Circuit After 2.23% Listing Premium, Up 7.32%
📅 3 days ago

Diksha Polymers Share Price Hits 5% Upper Circuit After 2.23% Listing Premium, Up 7.32%

Diksha Polymers made a positive debut on the BSE SME platform on June 24, 2026. The stock is listed at ₹114.50, a 2.23% premium over its IPO price of ₹112 per share. Buying interest remained strong after listing, pushing the share price to its 5% upper circuit of ₹120.20, taking the gain to 7.32% above…

Read more 12
Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition
📅 5 days ago

Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition

Aurobindo Pharma shares edged lower on June 22, 2026, despite a significant regulatory win announced before market open. Aurobindo Pharma USA, a wholly-owned subsidiary, received approval from the US Federal Trade Commission to proceed with the $250 million acquisition of Lannett Company LLC on a cash-free, debt-free basis. It inclusive of normalized working capital, with…

Read more 12
Idorsia Stock Surges 24% on Debt Refinancing Deal, June 19
📅 8 days ago

Idorsia Stock Surges 24% on Debt Refinancing Deal, June 19

Idorsia stock surges 24% to 5.78 CHF after refinancing debt and extending liquidity to 2028. Swiss biotech advances insomnia drug development.

Read more 12
FTSE 100 Rises 0.85% as US-Iran Deal Hopes Boost Risk Sentiment Despite UK GDP Dip
📅 15 days ago

FTSE 100 Rises 0.85% as US-Iran Deal Hopes Boost Risk Sentiment Despite UK GDP Dip

The FTSE 100 index rose by 0.85% in recent trading sessions as investor sentiment improved following renewed hopes of a potential diplomatic agreement between the United States and Iran. The positive global mood helped offset weaker economic data from the United Kingdom, where GDP figures showed a slight dip. The movement in the FTSE 100…

Read more 12
FDA Issues Alert: 6,408 Cases (160,200 lbs) of Farm Rich Pizza Snack Recalled Over Possible Metal Contamination
📅 15 days ago

FDA Issues Alert: 6,408 Cases (160,200 lbs) of Farm Rich Pizza Snack Recalled Over Possible Metal Contamination

The FDA officially flagged a serious metal contamination risk on June 9, 2026. Rich Products Corp voluntarily recalled 6,408 cases totaling 160,200 pounds of Farm Rich Pizza Cheese Crunchers after the products were found to potentially contain metal pieces. Rich Products Corporation is a Buffalo, New York-based company and the maker of the Farm Rich…

Read more 12
Alembic Pharmaceuticals Shares Jump 3% After US FDA Tentatively Approves Larotrectinib Capsules
📅 16 days ago

Alembic Pharmaceuticals Shares Jump 3% After US FDA Tentatively Approves Larotrectinib Capsules

Alembic Pharmaceuticals shares rose nearly 3% in trading after the company announced that the US Food and Drug Administration (FDA) granted tentative approval for its Larotrectinib capsules. The development marks a positive milestone for the Indian pharmaceutical company as it continues to expand its presence in the regulated US market. The announcement triggered strong investor…

Read more 12
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
📅 18 days ago

Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally

Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…

Read more 12
Panacea Biotec Soars 11.89% to 52-Week High After Launch of EU-Funded DENSTAR Project
📅 18 days ago

Panacea Biotec Soars 11.89% to 52-Week High After Launch of EU-Funded DENSTAR Project

Panacea Biotec is having its best week in years. The stock surged 11.89% to a fresh 52-week high of ₹619.05 on June 9, 2026, on the NSE, rallying from a 52-week low of ₹293.10, for an 111% climb in under twelve months. The trigger was the official launch of the DENSTAR project, a 48-month, EU-backed…

Read more 12
South Korea Cabinet Approves Decree for $350 Billion U.S. Investment Plan
📅 18 days ago

South Korea Cabinet Approves Decree for $350 Billion U.S. Investment Plan

South Korea has taken a major step in implementing its $350 billion investment commitment to the United States after the Cabinet approved a presidential decree on June 9, 2026. The decision creates the legal framework needed to launch one of the largest overseas investment programs ever backed by Seoul. The package includes $200 billion for…

Read more 12

2616.HK News FAQ